人类疱疹病毒6型（HHV-6）及其对人类免疫缺陷病毒（HIV）的体外影响。
Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV).
作者信息
Pietroboni G R, Harnett G B, Farr T J, Bucens M R
机构信息
Virus Laboratory, Queen Elizabeth II Medical Centre, Nedlands, Western Australia.
出版信息
J Clin Pathol. 1988 Dec;41(12):1310-2. doi: 10.1136/jcp.41.12.1310.
Abstract
Human herpes virus type 6 (HHV-6) was isolated from the peripheral blood lymphocytes of a patient infected with human immunodeficiency virus (HIV). Antibodies to this herpes virus were found to be widespread among adults and children in Western Australia. Co-infection studies indicated that HIV replication was inhibited by the presence of HHV-6.
摘要
人类疱疹病毒6型（HHV-6）是从一名感染人类免疫缺陷病毒（HIV）的患者外周血淋巴细胞中分离出来的。在西澳大利亚州的成人和儿童中发现，针对这种疱疹病毒的抗体广泛存在。共感染研究表明，HHV-6的存在会抑制HIV的复制。
相似文献
1
Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV).
J Clin Pathol. 1988 Dec;41(12):1310-2. doi: 10.1136/jcp.41.12.1310.
2
Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro.
J Virol Methods. 1989 Apr-May;24(1-2):85-90. doi: 10.1016/0166-0934(89)90010-4.
3
Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.
J Virol. 1989 Feb;63(2):970-3. doi: 10.1128/JVI.63.2.970-973.1989.
4
Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.
J Virol. 1989 May;63(5):2361-5. doi: 10.1128/JVI.63.5.2361-2365.1989.
5
Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo.
J Gen Virol. 1998 Feb;79 ( Pt 2):213-20. doi: 10.1099/0022-1317-79-2-213.
6
Inhibition of human immunodeficiency virus 1 (HIV-1) by variant B of human herpesvirus 6 (HHV-6).
New Microbiol. 1999 Jul;22(3):161-71.
7
8
[Seroepidemiologic study of human herpesvirus-6 in intravenous drug addicts, with and without infection caused by human immunodeficiency virus type 1].
Med Clin (Barc). 1992 Jul 4;99(6):210-2.
9
Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.
J Infect Dis. 2016 Jul 1;214(1):36-44. doi: 10.1093/infdis/jiw076. Epub 2016 Feb 24.
10
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
Lancet. 1986 Sep 20;2(8508):660-2.
引用本文的文献
1
Seroprevalence of antibodies against human herpesvirus 6 in the Quebec City area.
Can J Infect Dis. 1992 Jul;3(4):179-84. doi: 10.1155/1992/837029.
2
Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes.
Virus Genes. 2011 Jun;42(3):369-76. doi: 10.1007/s11262-011-0585-9. Epub 2011 Feb 22.
3
Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.
J Virol. 1999 May;73(5):4019-28. doi: 10.1128/JVI.73.5.4019-4028.1999.
4
Human herpesvirus 6.
Clin Microbiol Rev. 1997 Jul;10(3):521-67. doi: 10.1128/CMR.10.3.521.
5
Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals.
J Clin Microbiol. 1993 May;31(5):1262-7. doi: 10.1128/jcm.31.5.1262-1267.1993.
6
The distribution of antibodies to HHV-6 compared with other herpesviruses in young children.
Epidemiol Infect. 1990 Dec;105(3):603-7. doi: 10.1017/s095026880004824x.
7
Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.
J Clin Microbiol. 1990 Feb;28(2):211-5. doi: 10.1128/jcm.28.2.211-215.1990.
8
Isolation of HHV-6-related virus from children affected by infectious syndrome.
Arch Virol. 1990;110(1-2):143-9. doi: 10.1007/BF01310711.
9
Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds.
Antimicrob Agents Chemother. 1990 Dec;34(12):2417-9. doi: 10.1128/AAC.34.12.2417.
10
Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes.
J Virol. 1991 Oct;65(10):5597-604. doi: 10.1128/JVI.65.10.5597-5604.1991.
本文引用的文献
1
Enhancement of infectivity of murine cytomegalovirus in vitro by centrifugal inoculation.
J Virol. 1968 Sep;2(9):853-8. doi: 10.1128/JVI.2.9.853-858.1968.
2
HBLV (or HHV-6) in human cell lines.
Nature. 1987;329(6136):207. doi: 10.1038/329207a0.
3
Genomic analysis of the human B-lymphotropic virus (HBLV).
Science. 1986 Oct 31;234(4776):601-3. doi: 10.1126/science.3020691.
4
Isolation of human herpesvirus 6 from saliva.
Lancet. 1988 May 7;1(8593):1059. doi: 10.1016/s0140-6736(88)91884-3.
5
Age prevalence of antibody to human herpesvirus 6.
Lancet. 1988 May 7;1(8593):1058-9. doi: 10.1016/s0140-6736(88)91883-1.
6
Human B-lymphotropic virus in Germany.
Lancet. 1987 Sep 19;2(8560):694. doi: 10.1016/s0140-6736(87)92490-1.
7
A novel lymphotropic herpesvirus.
Lancet. 1987 Aug 15;2(8555):390-2. doi: 10.1016/s0140-6736(87)92404-4.
8
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.
Science. 1986 Oct 31;234(4776):596-601. doi: 10.1126/science.2876520.
Zotero 插件